NCT02504788 A Prospective Study of the Impact of Hippocampal Avoidance During Whole Brain Radiotherapy on Neurocognitive Function Decline Status RECRUITING Phase NA
NCT02490878 Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radionecrosis After Radiosurgery for Brain Metastases Status TERMINATED Phase PHASE2
NCT02460874 Glyburide vs Placebo as Prophylaxis Against Cerebral Edema in Patients Receiving Radiosurgery for Brain Metastases (RAD 1502/UAB 1593) Status TERMINATED Phase PHASE1/PHASE2
NCT02460068 A Study of Fotemustine(FTM) Vs FTM and Ipilimumab (IPI) or IPI and Nivolumab in Melanoma Brain Metastasis Status UNKNOWN Phase PHASE3
NCT02390518 Stereotactic Radiosurgery Dose Escalation for Brain Metastases Status RECRUITING Phase PHASE1
NCT02374242 Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02338011 Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases) Status UNKNOWN Phase PHASE2/PHASE3
NCT02328300 FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions Status WITHDRAWN Phase N/A
NCT02311556 Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging Status COMPLETED Phase PHASE1
NCT02308020 A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer, Non-small Cell Lung Cancer, or Melanoma That Has Spread to the Brain Status COMPLETED Phase PHASE2
NCT02284490 High-dose Pemetrexed to Treat Lung Adenocarcinoma With Brain Metastases Status UNKNOWN Phase PHASE2
NCT02220491 Whole Brain Radiotherapy Versus Volumetric Modulated Arc Therapy for Brain Metastases Status COMPLETED Phase NA
NCT02215512 Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases Status COMPLETED Phase PHASE1
NCT02187822 Fractionated Stereotactic Radiotherapy (FSRT) in Treatment of Brain Metastases Status TERMINATED Phase PHASE1
NCT02185352 Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain Metastases Status UNKNOWN Phase PHASE2
NCT02147028 Hippocampal Sparing Whole Brain Radiotherapy vs Conventional Whole Brain Radiotherapy in Patients With Brain Metastases Status COMPLETED Phase PHASE2
NCT02115139 GEM STUDY: Radiation And Yervoy in Patients With Melanoma and Brain Metastases Status COMPLETED Phase PHASE2
NCT02104193 Simvastatin Effect on Radiation Therapy of Brain Metastases Status COMPLETED Phase PHASE2
NCT02097732 Ipilimumab Induction in Patients With Melanoma Brain Metastases Receiving Stereotactic Radiosurgery Status TERMINATED Phase PHASE2
NCT02085070 MK-3475 in Melanoma and NSCLC Patients With Brain Metastases Status COMPLETED Phase PHASE2